Coston McIsaac & Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-438
| Closed | -$9K | – | 835 |
|
|
2024
Q4 | $9K | Sell |
438
-122
| -22% | -$2.51K | ﹤0.01% | 508 |
|
|
2024
Q3 | $10 | Hold |
560
| – | – | ﹤0.01% | 501 |
|
|
2024
Q2 | $9K | Sell |
560
-163
| -23% | -$2.62K | ﹤0.01% | 490 |
|
|
2024
Q1 | $10K | Hold |
723
| – | – | ﹤0.01% | 476 |
|
|
2023
Q4 | $7K | Hold |
723
| – | – | ﹤0.01% | 527 |
|
|
2023
Q3 | $7K | Hold |
723
| – | – | ﹤0.01% | 509 |
|
|
2023
Q2 | $5K | Hold |
723
| – | – | ﹤0.01% | 611 |
|
|
2023
Q1 | $6K | Hold |
723
| – | – | ﹤0.01% | 569 |
|
|
2022
Q4 | $6 | Hold |
723
| – | – | ﹤0.01% | 572 |
|
|
2022
Q3 | $5K | Hold |
723
| – | – | ﹤0.01% | 515 |
|
|
2022
Q2 | $5K | Buy |
+723
| New | +$5K | ﹤0.01% | 353 |
|